XML 12 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements Of Operations (USD $)
In Thousands, except Share data
3 Months Ended9 Months Ended119 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Costs and expenses:     
Research and development$ 533$ 726$ 1,720$ 2,246$ 40,990
Selling, general and administrative1,2881,3804,0074,57738,317
Merger transaction costs    5,470
Restructuring expense, net    2,413
Loss on impairment of in-process research and development    6,000
Total costs and expenses1,8212,1065,7276,82393,190
Loss from operations(1,821)(2,106)(5,727)(6,823)(93,190)
Gain on bargain purchase    25,282
Gain on assignment of patent rights  2,000 2,000
Interest and other income13252,026
Interest and other expense(2)(3)(9)(7)(443)
Income (loss) before income taxes(1,822)(2,106)(3,734)(6,825)(64,325)
Benefit from income taxes    2,281
Net income (loss)(1,822)(2,106)(3,734)(6,825)(62,044)
Less: Accretion of redeemable convertible preferred stock    (245)
Less: Deemed preferred stock dividend for additional common shares issuable under anti-dilution provisions    (781)
Net income (loss) available to common stockholders$ (1,822)$ (2,106)$ (3,734)$ (6,825)$ (63,070)
Net loss available to common stockholders per share:     
Basic and Diluted$ (0.17)$ (0.24)$ (0.38)$ (0.81) 
Weighted average shares outstanding:     
Basic and Diluted10,499,4728,817,7939,821,7068,401,340